secwatch.observer — SEC 8-K summary
======================================

Issuer:     Humacyte, Inc. (HUMA)
CIK:        0001818382
Form:       8-K
Filed at:   2025-12-16T23:59:59+00:00
Accession:  0001104659-25-121674
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Humacyte enters $60M at-the-market equity offering with TD Cowen
----------------------------------------------------------------

- Up to $60M in common stock may be sold from time to time through TD Securities (USA) LLC as agent.
- TD Cowen will receive a commission of up to 3.0% of gross proceeds.
- Net proceeds to fund commercialization of Symvess in vascular trauma, pipeline, and working capital.
- Company is not obligated to sell any shares; ATM allows sales at prevailing market prices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818382/000110465925121674/0001104659-25-121674-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818382/000110465925121674/tm2533475d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-121674

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer